|
Volumn 7, Issue 1, 2013, Pages 1-6
|
An economic perspective on personalized medicine
|
Author keywords
Clinical practice; Companion molecular diagnostics; Healthcare; Incentives; Personalized medicine; Translational genomics
|
Indexed keywords
BIOLOGICAL MARKER;
ACCESS TO INFORMATION;
ALGORITHM;
CLINICAL DECISION MAKING;
CLINICAL PRACTICE;
CLINICAL RESEARCH;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DATA MINING;
DRUG INDUSTRY;
DRUG MARKETING;
ELECTRONIC MEDICAL RECORD;
EVIDENCE BASED MEDICINE;
FALSE POSITIVE RESULT;
FOOD AND DRUG ADMINISTRATION;
GENOMICS;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HEALTH CARE NEED;
HEALTH CARE QUALITY;
HEALTH CARE UTILIZATION;
HUMAN;
INFORMATION RETRIEVAL;
MATHEMATICAL ANALYSIS;
MEDICAL CARE;
MEDICAL INFORMATICS;
MOLECULAR DIAGNOSTICS;
PATIENT DECISION MAKING;
PERSONALIZED MEDICINE;
PREDICTION;
PRESCRIPTION;
PRIORITY JOURNAL;
REIMBURSEMENT;
REVIEW;
RISK ASSESSMENT;
THERANOSTICS;
|
EID: 84877064737
PISSN: 18776558
EISSN: 18776566
Source Type: Journal
DOI: 10.1186/1877-6566-7-1 Document Type: Review |
Times cited : (63)
|
References (4)
|